PMID- 31598596 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20200930 IS - 2618-6500 (Electronic) IS - 2148-5046 (Print) IS - 2148-5046 (Linking) VI - 34 IP - 3 DP - 2019 Sep TI - Systemic Lupus Erythematosus and Angioedema: A Cross-Sectional Study From the National Inpatient Sample. PG - 301-307 LID - 10.5606/ArchRheumatol.2019.7149 [doi] AB - OBJECTIVES: This cross-sectional study aims to investigate the odds of developing angioedema (AE) in systemic lupus erythematosus (SLE) populations compared to non-SLE populations in hospital settings in the United States using a nationwide database. MATERIALS AND METHODS: We used the data from the National Inpatient Sample for the years 2012 to 2014. We constructed two models for multivariate logistic regression analysis. Model 1 was designed to adjust demographic information, while model 2 included each factor in model 1 and additionally accounted for AE-related comorbidities. RESULTS: A total of 90,485 hospitalizations with an AE diagnosis were identified for the years 2012 to 2014, among which 1,505 hospitalizations had both SLE and AE. Compared to those without SLE, AE patients with SLE were younger and included more females. In AE hospitalizations, SLE was associated with higher odds of AE-related comorbidities including atopic disorder, leukocytoclastic vasculitis, eosinophilia, and infections. SLE was associated with higher odds of AE both as all inpatient diagnosis and as principal diagnosis (unadjusted odds ratio [OR] 3.24, 95% confidence interval [CI] 2.87-3.63, p<0.001, model 1 adjusted OR 2.54, 95% CI 2.26-2.86, p<0.001, model 2 adjusted OR 1.71, 95% CI 1.51-1.93, p<0.001). CONCLUSION: Our study demonstrates that SLE is associated with higher odds of having AE, including severe AE as the principal reason for inpatient admission. SLE is possibly an independent risk factor for AE. CI - Copyright (c) 2019, Turkish League Against Rheumatism. FAU - Luo, Yiming AU - Luo Y AD - Department of Medicine, Mount Sinai St. Luke's and Mount Sinai West Hospitals, New York, United States. FAU - Fan, Xiaowen AU - Fan X AD - Department of Medicine, Mount Sinai St. Luke's and Mount Sinai West Hospitals, New York, United States. FAU - Jiang, Changchuan AU - Jiang C AD - Department of Medicine, Mount Sinai St. Luke's and Mount Sinai West Hospitals, New York, United States. FAU - Ramos-Rodriguez, Alvaro AU - Ramos-Rodriguez A AD - Department of Medicine, Mount Sinai St. Luke's and Mount Sinai West Hospitals, New York, United States. FAU - Wen, Yumeng AU - Wen Y AD - Department of Medicine, Mount Sinai St. Luke's and Mount Sinai West Hospitals, New York, United States. FAU - Zhang, Jianglin AU - Zhang J AD - Department of Rheumatology and Immunology, China Pla General Hospital, Beijing, China. FAU - Huang, Feng AU - Huang F AD - Department of Respiratory Medicine, China Pla General Hospital, Beijing, China. FAU - Guan, Xizhou AU - Guan X AD - Department of Respiratory Medicine, China Pla General Hospital, Beijing, China. FAU - Xu, Jiehui AU - Xu J AD - Department of Medicine, Weill Cornell Medical College, New York, United States. LA - eng PT - Journal Article DEP - 20190128 PL - Turkey TA - Arch Rheumatol JT - Archives of rheumatology JID - 101639000 PMC - PMC6768776 OTO - NOTNLM OT - Angioedema OT - National Inpatient Sample OT - cross-sectional study OT - epidemiology OT - systemic lupus erythematosus COIS- Conflict of Interest: The authors declared no conflicts of interest with respect to the authorship and/or publication of this article. EDAT- 2019/10/11 06:00 MHDA- 2019/10/11 06:01 PMCR- 2019/01/28 CRDT- 2019/10/11 06:00 PHST- 2018/08/18 00:00 [received] PHST- 2018/11/20 00:00 [accepted] PHST- 2019/10/11 06:00 [entrez] PHST- 2019/10/11 06:00 [pubmed] PHST- 2019/10/11 06:01 [medline] PHST- 2019/01/28 00:00 [pmc-release] AID - 10.5606/ArchRheumatol.2019.7149 [doi] PST - epublish SO - Arch Rheumatol. 2019 Jan 28;34(3):301-307. doi: 10.5606/ArchRheumatol.2019.7149. eCollection 2019 Sep.